thiethylperazine has been researched along with 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistin, L; Briani, C; Cagnin, A; Chierichetti, F; Pizzolato, G; Tiberio, M | 1 |
1 other study(ies) available for thiethylperazine and 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
| Article | Year |
|---|---|
Thiethylperazine-induced parkinsonism: in vivo demonstration of dopamine D2 receptors blockade.
Topics: Basal Ganglia; Benzamides; Brain Mapping; Dopamine D2 Receptor Antagonists; Female; Humans; Iodine Isotopes; Middle Aged; Parkinsonian Disorders; Pyrrolidines; Thiethylperazine; Tomography, Emission-Computed, Single-Photon | 2004 |